成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

武漢敬康恩生物醫(yī)藥科技有限公司 Company Information
Company Name:    Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:    13720134139 +86 -0-15871494362
Email:    orders@jknbiochem.com
Nationality:    China
WebSite:    www.jknbiochem.com
Product List:    5821
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Product List
TGX-221 663619-89-4
PHA-767491(HCl) 845714-00-3
Ganetespib 888216-25-9
Moclobemide (Ro 111163) 71320-77-9
Ulocuplumab 1375830-34-4
Brontictuzumab 1447814-75-6
Research Grade Obexelimab 1690307-05-1
Vandortuzumab Vedotin 1471985-92-8
Amivantamab 2171511-58-1
GSK 429286A 864082-47-3
Sparsentan 254740-64-2
VR23 1624602-30-7
Anetumab Ravtansine 1375258-01-7
Fletikumab 1357158-22-5
Abituzumab 1105038-73-0
Lenzilumab 1229575-09-0
Research Grade Tafasitamab 1422527-84-1
CID 755673 521937-07-5
HMN-214 173529-46-9
LMK-235 1418033-25-6
SB 366791 472981-92-3
Tirzepatide 2023788-19-2
Tarextumab 1359940-55-8
Anifrolumab 1326232-46-5
Emibetuzumab 1365287-97-3
Lumretuzumab 1448327-63-6
SKF38393 HCl 62717-42-4
Eldelumab 946414-98-8
Ralpancizumab 1407495-04-8
Denintuzumab Mafodotin 1399672-02-6
Lacutamab 2187368-16-5
semaglutide 99291-20-0
GW0742 317318-84-6
A66 1166227-08-2
Apoptozole 1054543-47-3
APS-2-79 2002381-31-7
mu-conotoxin 936616-33-0
AG 490 133550-30-8
Dapirolizumab Pegol 1416147-64-2
Coltuximab Ravtansine 1269764-99-9
Firivumab 1443004-15-6
Lokivetmab 1533403-95-0
Kartogenin 4727-31-5
Oprozomib;ONX-0912 935888-69-0
FPS-ZM1 945714-67-0
KC7F2 927822-86-4
HLCL-61 1158279-20-9
Avelumab 1537032-82-8
Reversine 656820-32-5
Scriptaid 287383-59-9
Tovetumab 1243266-04-7
Enfortumab Vedotin 1346452-25-2
Pasotuxizumab 1442657-12-6
Begelomab 1403744-56-8
BLU-945 2660250-10-0
SW-033291 459147-39-8
Daprodustat;GSK1278863 960539-70-2
Idarucizumab 1362509-93-0
Aducanumab 1384260-65-4
Bimekizumab 1418205-77-2
Guselkumab 1350289-85-8
Tosatoxumab 1374419-41-6
Bococizumab 1407495-02-6
Vanucizumab 1448221-05-3
Vitamin K2 (Mk7) 2124-57-4
GW2580 870483-87-7
Vidofludimus;4SC-101 717824-30-1
Stattic 19983-44-9
AZD9496 1639042-08-2
ON123300 1357470-29-1
CC122 1015474-32-4
BMS-986165 1609392-27-9
Otlertuzumab 1372645-37-8
Go 6983 133053-19-7
Sofituzumab Vedotin 1418200-58-4
Ontuxizumab 946415-62-9
Remtolumab 1791410-27-9
Evinacumab 1446419-85-7
3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]- 2747162-85-0
WP 1066 857064-38-1
BAY-57-1293;Pritelivir 348086-71-5
Tazemetostat (EPZ-6438) 1403254-99-8
BLU-9931 1538604-68-0
Durvalumab 1428935-60-7
Atezolizumab 1380723-44-3
Varlilumab 1393344-72-3
dinutuximab 1363687-32-4
UCB-9260 1515888-53-5
Vantictumab 1345009-45-1
Lifastuzumab Vedotin 1401812-88-1
Lulizumab Pegol 1421830-13-8
Imalumab 1430205-07-4
PD 123319 ditrifluoroacetate 136676-91-0
SB 742457 607742-69-8
SH-4-54 1456632-40-8
Vobarilizumab 1628814-88-9
Codrituzumab 1365267-33-9
Margetuximab 1350624-75-7
Abrilumab 1342290-43-0
Emactuzumab 1448221-67-7
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2007©  ChemicalBook. All rights reserved.